Sept 25 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS - TERRASCEND WILL HAVE OPTION TO PURCHASE
UP TO
ADDITIONAL $105 MILLION OF CANNABIS CONCENTRATE OVER SAME
PERIOD, IN DEAL
* MEDIPHARM LABS - DEAL HAS OPTION FOR 12 MONTH MUTUAL
EXTENSION
WHERE IF EXTENDED TERRASCEND WOULD BUY AT LEAST ABOUT $10
MILLION CANNABIS CONCENTRATE
* MEDIPHARM LABS AND TERRASCEND ENTER MAJOR PRIVATE LABEL
CONCENTRATE SUPPLY AGREEMENT WITH POTENTIAL VALUE UP TO $192
MILLION
* MEDIPHARM LABS - WILL SUPPLY TERRASCEND WITH ABOUT $27
MILLION
OF PRIVATE LABEL CANNABIS DISTILLATE, OVER 24-MONTHS COMMENCING
SEPT
* MEDIPHARM LABS CORP - MULTI-YEAR SUPPLY AGREEMENT TO
SUPPORT
TERRASCEND'S ROLL OUT OF CANADIAN CANNABIS 2.0 DERIVATIVE
PRODUCTS
Source text: https://reut.rs/2n2bM1Z
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))